We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
1
Amgen
AMGN
$198B
$223M 2.96%
1,075,050
+380,562
+55% +$75M
BIIB icon
2
Biogen
BIIB
$30B
$179M 2.39%
507,936
+205,294
+68% +$70.7M
MSFT icon
3
Microsoft
MSFT
$2.95T
$162M 2.15%
1,415,255
-74,903
-5% -$8.12M
AMZN icon
4
Amazon
AMZN
$2.66T
$153M 2.03%
1,526,460
+5,540
+0.4% +$521K
AAPL icon
5
Apple
AAPL
$4.81T
$145M 1.93%
2,575,636
-106,836
-4% -$5.56M
REGN icon
6
Regeneron Pharmaceuticals
REGN
$70.8B
$140M 1.86%
346,383
+157,800
+84% +$60.1M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.24T
$125M 1.66%
2,068,260
-40,020
-2% -$2.42M
CELG
8
DELISTED
Celgene Corp
CELG
$115M 1.53%
1,286,204
+170,225
+15% +$15M
GILD icon
9
Gilead Sciences
GILD
$162B
$103M 1.37%
1,339,293
+437,628
+49% +$33.1M
BABA icon
10
Alibaba
BABA
$283B
$91.8M 1.22%
557,372
-56,320
-9% -$9.97M
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$122B
$88.3M 1.17%
458,151
+131,345
+40% +$23.4M
MRK icon
12
Merck
MRK
$312B
$88.1M 1.17%
1,301,480
+856,912
+193% +$54.6M
META icon
13
Meta Platforms (Facebook)
META
$1.63T
$85.6M 1.14%
520,598
+19,639
+4% +$3.56M
XOM icon
14
ExxonMobil
XOM
$629B
$79.4M 1.06%
933,476
-11,244
-1% -$919K
PG icon
15
Procter & Gamble
PG
$345B
$74.1M 0.99%
890,863
+123,371
+16% +$10.1M
V icon
16
Visa
V
$677B
$73.1M 0.97%
486,741
+11,870
+2% +$1.69M
ILMN icon
17
Illumina
ILMN
$29.1B
$67.9M 0.9%
190,134
+81,544
+75% +$26.1M
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
$66.8M 0.89%
480,820
+186,778
+64% +$23.4M
DIS icon
19
Walt Disney
DIS
$167B
$65.1M 0.87%
556,649
+136,595
+33% +$15.2M
BMY icon
20
Bristol-Myers Squibb
BMY
$124B
$63.7M 0.85%
1,026,637
+68,092
+7% +$4.04M
JPM icon
21
JPMorgan Chase
JPM
$918B
$60.9M 0.81%
539,933
+23,360
+5% +$2.65M
JNJ icon
22
Johnson & Johnson
JNJ
$603B
$58.7M 0.78%
424,729
+236
+0.1% +$31.4K
HD icon
23
Home Depot
HD
$331B
$58.5M 0.78%
282,220
-44,095
-14% -$8.88M
ORCL icon
24
Oracle
ORCL
$366B
$58M 0.77%
1,124,400
+397,211
+55% +$19.3M
CSCO icon
25
Cisco
CSCO
$442B
$52.9M 0.7%
1,087,322
-7,516
-0.7% -$338K

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.